Skip to main content

Table 4 Spearman’s rank correlation analyses between QOL and continuous liver function variables

From: The association of liver function and quality of life of patients with liver cancer

 

mean ± SD

ln(Albumin)

ln(Bilirubin)

ln(INR)

ln(ALP)

ln(ALT)

ln(Alb/ALP)

ln(ALP/plt)

rho

p

rho

p

rho

p

rho

p

rho

p

rho

p

rho

p

EORTC QLQ-C30

 Physical functioning

72.27 ± 23.74

0.404

< 0.001

− 0.235

< 0.001

−0.202

< 0.001

− 0.271

< 0.001

− 0.030

0.514

0.337

< 0.001

− 0.145

0.002

 Role functioning

74.61 ± 32.60

0.318

< 0.001

− 0.262

< 0.001

− 0.194

< 0.001

− 0.304

< 0.001

− 0.187

< 0.001

0.350

< 0.001

− 0.141

0.002

 Emotional functioning

70.67 ± 25.48

− 0.023

0.612

− 0.055

0.232

− 0.018

0.693

− 0.076

0.099

− 0.054

0.239

0.066

0.154

−0.044

0.345

 Cognitive functioning

76.80 ± 24.68

0.133

0.004

−0.115

0.013

−0.146

0.002

−0.072

0.120

−0.029

0.533

0.094

0.041

−0.071

0.121

 Social functioning

68.46 ± 30.33

0.151

0.001

−0.147

0.001

−0.116

0.012

−0.235

< 0.001

− 0.069

0.135

0.241

< 0.001

−0.082

0.076

 Global quality of life

52.22 ± 26.34

0.257

< 0.001

−0.232

< 0.001

−0.167

< 0.001

− 0.230

< 0.001

−0.025

0.595

0.265

< 0.001

−0.070

0.131

 Fatigue

42.93 ± 30.23

−0.321

< 0.001

0.285

< 0.001

0.246

< 0.001

0.316

< 0.001

0.127

0.006

−0.354

< 0.001

0.163

< 0.001

 Nausea & vomiting

11.26 ± 21.41

−0.114

0.013

0.180

< 0.001

0.1406

0.002

0.178

< 0.001

0.093

0.043

−0.183

< 0.001

0.017

0.721

 Pain

32.87 ± 31.97

−0.106

0.022

0.066

0.152

0.084

0.069

0.238

< 0.001

0.050

0.278

−0.229

< 0.001

− 0.003

0.953

 Dyspnoea

29.73 ± 31.46

−0.244

< 0.0001

0.171

< 0.001

0.153

0.001

0.166

< 0.001

0.020

0.661

−0.201

< 0.001

0.111

0.016

 Insomnia

41.88 ± 36.41

−0.165

< 0.001

0.110

0.017

0.104

0.024

0.215

< 0.001

0.111

0.016

−0.228

< 0.001

0.077

0.095

 Appetite loss

32.34 ± 35.88

−0.200

< 0.001

0.245

< 0.001

0.134

0.004

0.300

< 0.001

0.086

0.061

−0.304

< 0.001

0.071

0.121

 Constipation

16.67 ± 27.13

−0.057

0.217

0.006

0.890

−0.007

0.885

−0.019

0.684

0.024

0.598

0.008

0.857

−0.048

0.297

 Diarrhea

16.45 ± 26.87

−0.164

< 0.001

0.222

< 0.001

0.146

0.001

0.126

0.006

0.119

0.009

−0.158

< 0.001

0.143

0.002

 Financial difficulties

51.20 ± 37.22

−0.093

0.044

0.085

0.066

0.086

0.061

0.159

< 0.001

0.062

0.178

−0.163

< 0.001

0.077

0.093

EORTC QLQ-HCC18

 Fatigue

35.23 ± 25.86

−0.305

< 0.001

0.258

< 0.001

0.209

< 0.001

0.295

< 0.001

0.122

0.008

−0.329

< 0.001

0.148

0.001

 Body Image

25.35 ± 22.98

−0.280

< 0.001

0.255

< 0.001

0.152

0.001

0.287

< 0.001

0.064

0.164

−0.320

< 0.001

0.106

0.021

 Jaundice

23.41 ± 22.15

−0.094

0.041

0.226

< 0.001

0.110

0.017

0.096

0.038

0.082

0.074

−0.101

0.027

0.126

0.006

 Nutrition

26.96 ± 21.35

−0.225

< 0.001

0.276

< 0.001

0.149

0.001

0.341

< 0.001

0.134

0.004

−0.343

< 0.001

0.136

0.003

 Pain

23.34 ± 24.57

−0.077

0.096

0.144

0.002

0.094

0.042

0.182

< 0.001

0.057

0.217

−0.178

< 0.001

0.038

0.407

 Fever

6.60 ± 14.39

−0.220

< 0.001

0.117

0.011

0.193

< 0.001

0.097

0.036

0.016

0.735

−0.131

0.004

0.041

0.378

 Sex life

28.74 ± 34.76

−0.053

0.249

0.095

0.040

0.129

0.005

0.170

< 0.001

0.041

0.379

−0.157

< 0.001

0.166

< 0.001

 Abdominal swelling

33.33 ± 35.43

−0.312

< 0.001

0.325

< 0.001

0.225

< 0.001

0.299

< 0.001

0.108

0.019

−0.343

< 0.001

0.175

0.001

Index-scores

 C30 index-score

30.69 ± 19.61

−0.272

< 0.001

0.250

< 0.0001

0.1927

< 0.001

0.301

< 0.0001

0.1245

0.007

−0.329

< 0.001

0.116

0.011

 HCC18 index-score

25.37 ± 17.21

−0.304

< 0.001

0.318

< 0.0001

0.2229

< 0.001

0.343

< 0.0001

0.1188

0.010

−0.371

< 0.001

0.187

< 0.001

  1. ALP alkaline phosphatase, ALT alanine transaminase, EORTC European Organization for Research and Treatment of Cancer, INR international normalized ratio, ln natural logarithm, MELD Model for End-stage Liver Disease, Plt platelet, rho Spearman’s rank correlation coefficient